Childhood deaths mount and maternity mortality doubles in the eastern Democratic Republic of the Congo as an Ebola outbreak in Ituri province climbs to 458 total cases by early December, compounded by community resistance, hospital attacks, and soaring clinical fears that are keeping patients away from essential care.
The health crisis unfolding in Ituri province continues to disproportionately impact vulnerable populations. Nearly one million people have been displaced by ongoing conflict in the region, with women and children accounting for approximately 80 per cent of those affected, according to the UN Office for the Coordination of Humanitarian Affairs. Since the outbreak emerged in mid-May, the crisis has accelerated into a complex emergency marked by acute security threats and deep-seated community mistrust.
Childhood Fatalities and the Collapsing Maternity Care Landscape
More than 300 children have succumbed to the virus since the outbreak began, according to the United Nations Children’s Fund. Youngsters represent nearly a quarter of all confirmed cases, yet they account for almost a third of total fatalities. Health officials report that weekly illnesses and deaths fluctuate as response teams battle access barriers, though overall totals reached 458 cases—comprising 410 confirmed and 48 probable infections—along with 263 deaths by early December, according to World Health Organization figures cited by UMN.
Parallel to the direct viral toll, a secondary health emergency has materialized among pregnant women. Maternal mortality across Ituri province has nearly doubled since the outbreak was declared. UNFPA data analyzed by taipeitimes.com show that maternal deaths rose from a weekly average of 3.1 earlier in the year to 5.8 deaths per week between May 25 and July 19. During that same period, the proportion of deaths occurring outside health centers jumped from 9.1 percent to 17.4 percent.
Fear of infection and widespread misconceptions are driving expectant mothers away from clinics. Esther Lutula, a 26-year-old resident of Bunia, stopped attending prenatal checkups because she feared being forced into isolation simply for having a fever.
Violence, Insecurity, and Attacks on Treatment Infrastructure
Response efforts face severe operational bottlenecks driven by armed conflict and hostile community resistance. Hot spots persist in Beni, Katwa, and Kalunguta, where contact tracing remains particularly challenging because contacts are frequently lost to follow-up. In one instance, infected healthcare workers’ total reached 43 illnesses, 12 of them fatal.
Tensions boiled over near Bunia when angry relatives set fire to Rwampara General Hospital after medical staff refused to release a patient’s body due to high contamination risks.
Malembe added that the crowd even set fire to tents that were being used as isolation wards
. Police deployed warning shots to disperse the rioters, and medical personnel at the facility were subsequently placed under military protection. Local residents voiced acute distress over the rapid progression of the illness. I am scared because people are dying very fast… we are really afraid,
a young taxi rider told BBC.
International Aid Deployments and Mobile Diagnostics
Humanitarian agencies and international bodies have scaled up financial and logistical support to stabilize the region. Meanwhile, roughly 13,000 community workers deployed by the Congolese health ministry alongside partners like Africa CDC, UNICEF, and the WHO have reached more than 2.4 million people with prevention information and conducted over 500,000 household visits (UN.org).
To accelerate testing, a mobile laboratory supported by the WHO and the World Food Programme operates at the DRC-Uganda border, delivering diagnostic results in roughly one hour and serving more than 94,000 people. MONUSCO peacekeeping forces have likewise increased their presence around medical facilities to safeguard response teams.
Clinical Trials and Vaccine Strategy Evaluations
Because the current outbreak involves the Bundibugyo species of the Ebola virus—for which no specific licensed treatments or preventive vaccines previously existed—researchers have mobilized clinical trials more rapidly than in past epidemics. A phase one vaccine trial for a Bundibugyo-specific candidate began in the United Kingdom, with a second trial launching in Canada. Additionally, a clinical trial evaluating an oral post-exposure prophylaxis medicine given for 10 days to high-risk contacts has enrolled over 25 patients across testing sites in Ituri province.
Concurrently, a WHO technical advisory group reviewed preliminary animal study data indicating that Ervebo—the licensed vaccine targeting the Zaire strain—may offer cross-protection against fatalities from the Bundibugyo species (UN.org). The advisory group recommended prioritizing Ervebo for evaluation within a randomized clinical trial while noting that a dedicated Bundibugyo vaccine remains the preferred long-term objective (UN.org).
